ReviewOncotarget2017
Anti-tumor activity of metformin: from metabolic and epigenetic perspectives.
Xilan Yu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
50 papers cite it
this paperpooled ittrialcites it
ReviewOncotarget2017
Xilan Yu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.